Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 21,750 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 21,750 | n/a |
| Jun 22, 2026 | Serina Therapeutics, Inc. (SER) | Grant/Award | 15,250 | n/a |
| Jun 15, 2026 | Serina Therapeutics, Inc. (SER) | Purchase | 5,100 | $8.9K |
| May 26, 2026 | Serina Therapeutics, Inc. (SER) | Purchase | 10,000 | $17.7K |
| Nov 11, 2025 | Serina Therapeutics, Inc. (SER) | Grant/Award | 10,000 | n/a |
| May 20, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 7,900 | n/a |
| Jan 15, 2025 | Serina Therapeutics, Inc. (SER) | Grant/Award | 40,000 | n/a |
| Nov 25, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 4,100 | n/a |
| Dec 29, 2023 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 4,100 | n/a |
| Jun 13, 2022 | Angion Biomedica Corp. (ANGN) | Grant/Award | 15,000 | n/a |